AU2003213963A1 - Method of treating or preventing autoimmune disease - Google Patents

Method of treating or preventing autoimmune disease

Info

Publication number
AU2003213963A1
AU2003213963A1 AU2003213963A AU2003213963A AU2003213963A1 AU 2003213963 A1 AU2003213963 A1 AU 2003213963A1 AU 2003213963 A AU2003213963 A AU 2003213963A AU 2003213963 A AU2003213963 A AU 2003213963A AU 2003213963 A1 AU2003213963 A1 AU 2003213963A1
Authority
AU
Australia
Prior art keywords
treating
autoimmune disease
preventing autoimmune
preventing
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003213963A
Other versions
AU2003213963A8 (en
Inventor
Terry L. Delovitch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John P Robarts Research Institute
Original Assignee
John P Robarts Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John P Robarts Research Institute filed Critical John P Robarts Research Institute
Publication of AU2003213963A1 publication Critical patent/AU2003213963A1/en
Publication of AU2003213963A8 publication Critical patent/AU2003213963A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003213963A 2002-04-08 2003-04-07 Method of treating or preventing autoimmune disease Abandoned AU2003213963A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37053502P 2002-04-08 2002-04-08
US60/370,535 2002-04-08
PCT/CA2003/000501 WO2003086457A2 (en) 2002-04-08 2003-04-07 Method of treating or preventing autoimmune disease

Publications (2)

Publication Number Publication Date
AU2003213963A1 true AU2003213963A1 (en) 2003-10-27
AU2003213963A8 AU2003213963A8 (en) 2003-10-27

Family

ID=29250541

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003213963A Abandoned AU2003213963A1 (en) 2002-04-08 2003-04-07 Method of treating or preventing autoimmune disease

Country Status (2)

Country Link
AU (1) AU2003213963A1 (en)
WO (1) WO2003086457A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0904214D0 (en) 2009-03-11 2009-04-22 Ucb Pharma Sa Biological products

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608068D0 (en) * 1986-04-02 1986-05-08 Cobbold S P Monoclonal antibodies
CA2070182C (en) * 1989-12-27 2002-12-24 John Ghrayeb Chimeric immunoglobulin for cd4 receptors
US6699466B1 (en) * 1999-08-05 2004-03-02 Research Corporation Technologies, Inc. IL-16 antagonist peptides and DNA encoding the peptides
WO2001010891A2 (en) * 1999-08-05 2001-02-15 Research Corporation Technologies, Inc. Il-16 antagonists
US6936426B2 (en) * 2000-10-06 2005-08-30 Harbor-Ucla Research And Education Institute Detection of antibody mediated inflammatory auto-immune disorders

Also Published As

Publication number Publication date
WO2003086457A2 (en) 2003-10-23
AU2003213963A8 (en) 2003-10-27
WO2003086457A3 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
AU2002243231A1 (en) Method of treating autoimmune diseases
AU2003219934A1 (en) Method of treatment or prevention of obesity
AU2002257936A1 (en) Methods of well treatment
EP1480658A4 (en) Methods of treating vascular disease
AU2003278361A1 (en) Method of water treatment
AU2003277596A1 (en) Method of deuterization
AU2002952834A0 (en) A method of treating an autoimmune disease
AUPS201002A0 (en) Method of treating shellfish
AU2003221005A1 (en) Method of wastewater treatment
AU2003222250A1 (en) Treatment of autoimmune diseases
AU2003213963A1 (en) Method of treating or preventing autoimmune disease
AUPR731901A0 (en) Method of treatment
AU2002951913A0 (en) Method of treatment
AU2003302271A1 (en) Methods of treating and/or preventing autoimmune diseases
AU2003252188A1 (en) Method of ore treatment
AU2003237199A1 (en) Method of treating multiple sclerosis
GB0221712D0 (en) Methods of treatment
AU2003220903A1 (en) Method of judging risk of peiodontal disease
AU2002247836A1 (en) Mycobacterrial estracts for treating autoimmune diseases
AU2003213601A1 (en) Case hardening of titanium
AU2003248679A1 (en) Treating disease using radium-225
AUPS079602A0 (en) Method of treatment
AU2002953042A0 (en) Method of treatment
GB0207091D0 (en) Method of treatment
AUPS219902A0 (en) Methods of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase